DiaSorin S.p.A. (DSRLF)
USD 109.01
(0.0%)
USD 109.01
(0.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 524.92 Million EUR | 0.58% |
| 2022 | 475.5 Million USD | 23.94% |
| 2021 | 383.65 Million USD | 25.78% |
| 2020 | 305.02 Million USD | 15.22% |
| 2019 | 264.72 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 221.38 Million EUR | 0.95% |
| 2024 Q1 | 138.12 Million EUR | -6.6% |
| 2023 FY | 478.24 Million USD | 0.58% |
| 2023 Q2 | 242.93 Million USD | 84.46% |
| 2023 Q4 | 229.1 Million USD | 92.52% |
| 2023 Q1 | 131.7 Million EUR | -49.66% |
| 2023 Q3 | 119 Million EUR | -51.02% |
| 2022 Q2 | 220.47 Million USD | 64.43% |
| 2022 Q1 | 134.08 Million EUR | -37.62% |
| 2022 FY | 475.5 Million USD | 23.94% |
| 2022 Q4 | 261.62 Million USD | 96.71% |
| 2022 Q3 | 133 Million EUR | -39.68% |
| 2021 Q1 | 96.01 Million EUR | -25.51% |
| 2021 Q2 | 135.9 Million EUR | 41.55% |
| 2021 Q3 | 130.06 Million EUR | -4.3% |
| 2021 Q4 | 214.94 Million EUR | 65.25% |
| 2021 FY | 383.65 Million USD | 25.78% |
| 2020 Q2 | 125.2 Million EUR | 59.56% |
| 2020 Q4 | 128.9 Million EUR | 66.81% |
| 2020 Q3 | 77.27 Million EUR | -38.28% |
| 2020 FY | 305.02 Million USD | 15.22% |
| 2020 Q1 | 78.46 Million EUR | -36.57% |
| 2019 Q1 | 73.69 Million EUR | 3.23% |
| 2019 FY | 264.72 Million USD | 0.0% |
| 2019 Q4 | 123.71 Million EUR | 77.25% |
| 2019 Q3 | 69.79 Million EUR | -48.91% |
| 2019 Q2 | 136.62 Million EUR | 85.39% |
| 2018 Q2 | 70.5 Million EUR | -5.39% |
| 2018 Q1 | 74.52 Million EUR | -16.27% |
| 2018 Q4 | 71.38 Million EUR | -2.24% |
| 2018 Q3 | 73.02 Million EUR | 3.57% |
| 2017 Q3 | 67.13 Million EUR | -3.79% |
| 2017 Q1 | 61.87 Million EUR | -6.72% |
| 2017 Q4 | 89.01 Million EUR | 32.59% |
| 2017 Q2 | 69.77 Million EUR | 12.76% |
| 2016 Q4 | 66.33 Million EUR | 6.54% |
| 2016 Q2 | 61.27 Million EUR | 13.03% |
| 2016 Q1 | 54.2 Million EUR | 1.1% |
| 2016 Q3 | 62.26 Million EUR | 1.62% |
| 2015 Q2 | 53.64 Million EUR | 10.79% |
| 2015 Q3 | 55.55 Million EUR | 3.55% |
| 2015 Q4 | 53.62 Million EUR | -3.47% |
| 2015 Q1 | 48.42 Million EUR | -15.3% |
| 2014 Q2 | 57.48 Million EUR | 2.04% |
| 2014 Q3 | 51.27 Million EUR | -10.8% |
| 2014 Q4 | 57.17 Million EUR | 11.5% |
| 2014 Q1 | 56.33 Million EUR | -9.15% |
| 2013 Q2 | 59.83 Million EUR | 19.85% |
| 2013 Q4 | 62.01 Million EUR | 15.05% |
| 2013 Q1 | 49.92 Million EUR | 0.0% |
| 2013 Q3 | 53.89 Million EUR | -9.93% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| American Bio Medica Corporation | 1.04 Million USD | -49940.515% |
| Arrayit Corporation | 6.19 Million USD | -8369.844% |
| Atlantic International Corp. | 5.57 Million USD | -9310.167% |
| Biocept, Inc. | 29.4 Million USD | -1685.398% |
| Bioqual, Inc. | 7.44 Million USD | -6947.136% |
| CardioGenics Holdings Inc | 772.14 Thousand USD | -67882.962% |
| DermTech, Inc. | 104.01 Million USD | -404.663% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 166.5 Million USD | -215.268% |
| HTG Molecular Diagnostics, Inc. | 22.62 Million USD | -2220.246% |
| iMD Companies, Inc. | 151.8 Thousand USD | -345679.894% |
| IDenta Corp. | 662.97 Thousand USD | -79077.194% |
| Interpace Biosciences, Inc. | 20.23 Million USD | -2494.528% |
| Integrative Health Technologies, Inc. | 38.88 Thousand USD | -1349981.016% |
| InVitro International | 661.32 Thousand USD | -79274.86% |
| Lumos Diagnostics Holdings Limited | 7.09 Million USD | -7295.393% |
| Many Bright Ideas Technologies Inc. | 58.11 Thousand USD | -903198.802% |
| Medical Imaging Corp. | 1.91 Million USD | -27351.882% |
| NovelStem International Corp. | 3.53 Million USD | -14737.615% |
| Optigenex Inc. | 1.28 Million USD | -40659.192% |
| PharmChem, Inc. | 2.93 Million USD | -17808.017% |
| Proteome Sciences plc | 3.26 Million USD | -15962.576% |
| Response Genetics, Inc | 25.31 Million USD | -1973.245% |
| Rennova Health, Inc. | 7.67 Million USD | -6736.933% |
| RushNet, Inc. | 1.78 Million USD | -29236.564% |
| ScreenPro Security Inc. | 3.23 Million USD | -16106.826% |
| Stella Diagnostics Inc. | 11.42 Million USD | -4493.745% |
| StageZero Life Sciences Ltd. | 7.34 Million USD | -7048.629% |
| Todos Medical Ltd. | 14.05 Million USD | -3633.995% |